AUNA on NYSE

AUNA S.A.

Price unavailable

Last updated Oct 16, 2026.

Overview

4.4BRevenue, fiscal 2024²

124.0MNet income, fiscal 2024²

Compare with another stock.

TickerAUNA on NYSE
IndustryServices-Offices & Clinics of Doctors of Medicine
Business address6, Rue Jean Monnet, Grand Duchy Of Luxembourg, L-2180³
Filer categoryAccelerated filer³

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from. Figures are in PEN, the currency the company reports in.

Key numbers, fiscal 2024

39.3%Gross margin²

17.9%Operating margin²

2.8%Net margin²

13.2%Revenue growth, 2024²

7.6%Return on equity²

577.6M PENFree cash flow²

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Business segments

Healthcare services in Colombia brought in 30% of the revenue AUNA S.A. broke down this way in fiscal 2025.

Healthcare services in Colombia1.4B PEN⁴30%down 0% from 2024
Oncosalud Peru1.2B PEN⁴25%up 9% from 2024
Healthcare services in Peru1.1B PEN⁴23%up 9% from 2024
Healthcare services in Mexico1.0B PEN⁴22%down 13% from 2024

Business segments by year

Business segments	2023	2024	2025
Healthcare services in Colombia	1.2B PEN	1.4B PEN	1.4B PEN
Oncosalud Peru	931.7M PEN	1.1B PEN	1.2B PEN
Healthcare services in Peru	883.9M PEN	995.8M PEN	1.1B PEN
Healthcare services in Mexico	1.1B PEN	1.2B PEN	1.0B PEN

Regions

PEMember brought in 44% of the revenue AUNA S.A. broke down this way in fiscal 2025.

PEMember1.9B PEN⁴44%up 9% from 2024
CO1.4B PEN⁴33%down 1% from 2024
M X1.0B PEN⁴24%down 13% from 2024

Regions by year

Regions	2023	2024	2025
PEMember	1.6B PEN	1.7B PEN	1.9B PEN
CO	1.2B PEN	1.4B PEN	1.4B PEN
M X	1.1B PEN	1.2B PEN	1.0B PEN

Where the money goes

Where each dollar of revenue went, fiscal 2024

Other costs

Other costs97¢4.3B PEN
Profit3¢124.0M PEN

Out of 4.4B PEN in revenue.²

Where each dollar of operating cash went, fiscal 2024

Capital spendingKept or used elsewhere

Capital spending14¢90.9M PEN
Kept or used elsewhere86¢577.6M PEN

Out of 668.5M PEN of cash from operations.²

Financial statements

Revenue²4.4B PEN in 2024+79% since 2022

Gross profit²1.7B PEN in 2024+96% since 2022

Operating income²783.8M PEN in 2024+208% since 2022

Net income²124.0M PEN in 2024

Every line of the income statement in the latest annual report, as filed.⁴

Period ending	2025-12-31	2024-12-31	2023-12-31
Insurance revenue	1.1B PEN	1.1B PEN	914.2M PEN
Healthcare services revenue	2.9B PEN	3.0B PEN	2.7B PEN
Sales of medicines	335.0M PEN	320.7M PEN	265.9M PEN
Total revenue from contracts with customers	4.4B PEN	4.4B PEN	3.9B PEN
Cost of sales and services	-2.7B PEN	-2.7B PEN	-2.4B PEN
Gross profit	1.7B PEN	1.7B PEN	1.4B PEN
Selling expenses	-220.9M PEN	-197.5M PEN	-193.9M PEN
Administrative expenses	-812.7M PEN	-788.7M PEN	-704.6M PEN
Loss for impairment of trade receivables	-48.1M PEN	-40.9M PEN	-5.7M PEN
Other expenses	0 PEN	-2.1M PEN	-20.9M PEN
Other income	43.2M PEN	87.6M PEN	50.1M PEN
Operating profit	625.3M PEN	783.8M PEN	560.3M PEN
Finance income	21.8M PEN	24.8M PEN	17.1M PEN
Finance income from exchange difference	193.0M PEN	0 PEN	75.9M PEN
Finance costs	-651.3M PEN	-591.9M PEN	-783.8M PEN
Finance costs from exchange difference	0 PEN	-41.7M PEN	0 PEN
Net finance cost	-436.5M PEN	-608.8M PEN	-690.8M PEN
Share of profit of equity-accounted investees	10.4M PEN	8.8M PEN	6.3M PEN
Income (loss) before tax	199.3M PEN	183.8M PEN	-124.2M PEN
Income tax expense	-88.4M PEN	-59.8M PEN	-90.2M PEN
Profit (loss) for the year	110.9M PEN	124.0M PEN	-214.3M PEN
Cash flow hedges	-292.0K PEN	3.8M PEN	13.8M PEN
Foreign operations Foreign currency translation differences	90.7M PEN	-409.7M PEN	390.2M PEN
Remeasurements of defined benefit liability	-78.0K PEN	1.5M PEN	-2.2M PEN
Change in fair value of put liability	0 PEN	0 PEN	40.4M PEN
Other investments at FVOCI net change in fair value	-1.1M PEN	1.1M PEN	188.0K PEN
Equity-accounted investees share of OCI	0 PEN	0 PEN	-42.0K PEN
Income tax	248.0K PEN	-1.7M PEN	-4.3M PEN
Other comprehensive income (loss) for the year, net of tax	89.4M PEN	-405.1M PEN	438.0M PEN
Total comprehensive income (loss) for the year	200.3M PEN	-281.2M PEN	223.7M PEN
Owner of the Company	97.6M PEN	110.3M PEN	-253.9M PEN
Non-controlling interest	13.3M PEN	13.7M PEN	39.6M PEN
Owner of the Company	180.5M PEN	-276.9M PEN	84.3M PEN
Non-controlling interest	19.9M PEN	-4.3M PEN	139.4M PEN
Basic earnings per share	1.32 PEN	1.64 PEN	-5.78 PEN
Diluted earnings per share	1.32 PEN	1.63 PEN	-5.78 PEN

Total assets²7.1B PEN in 2024+7% since 2022

Total liabilities²5.5B PEN in 2024+8% since 2022

Shareholders’ equity²1.6B PEN in 2024+175% since 2021

Cash²235.7M PEN in 2024+70% since 2021

Every line of the balance sheet in the latest annual report, as filed.⁴

Period ending	2025-12-31	2024-12-31	2023-12-31
Cash and cash equivalents	335.4M PEN	235.7M PEN	241.1M PEN
Trade accounts receivable	1.0B PEN	961.9M PEN	860.9M PEN
Other assets	258.5M PEN	253.3M PEN	222.7M PEN
Inventories	164.8M PEN	143.8M PEN	130.5M PEN
Derivative financial instruments	0 PEN	9.0M PEN	721.0K PEN
Other investments	30.2M PEN	100.2M PEN	93.1M PEN
Insurance contract assets	12.8M PEN	0 PEN	0 PEN
Total current assets	1.8B PEN	1.7B PEN	1.5B PEN
Trade accounts receivable	486.0K PEN	571.0K PEN	420.0K PEN
Other assets	26.9M PEN	24.4M PEN	21.6M PEN
Investments in associates and joint venture	29.8M PEN	25.4M PEN	20.6M PEN
Property, furniture, and equipment	2.3B PEN	2.3B PEN	2.6B PEN
Intangible assets	2.7B PEN	2.7B PEN	3.1B PEN
Right-of-use assets	113.1M PEN	131.1M PEN	139.4M PEN
Investment properties	6.3M PEN	6.1M PEN	7.0M PEN
Derivative financial instruments	54.0M PEN	58.5M PEN	81.5M PEN
Deferred tax assets	230.7M PEN	193.5M PEN	167.4M PEN
Other investments	702.0K PEN	282.0K PEN	289.0K PEN
Total non-current assets	5.5B PEN	5.4B PEN	6.1B PEN
Total assets	7.3B PEN	7.1B PEN	7.7B PEN
Loans and borrowings	316.3M PEN	654.2M PEN	385.3M PEN
Lease liabilities	29.3M PEN	32.5M PEN	31.9M PEN
Trade accounts payable	1.1B PEN	931.3M PEN	749.3M PEN
Other accounts payable	225.5M PEN	289.6M PEN	463.6M PEN
Provisions	10.2M PEN	12.2M PEN	19.1M PEN
Derivative financial instruments	22.9M PEN	15.3M PEN	0 PEN
Insurance contract liabilities	9.4M PEN	10.1M PEN	39.9M PEN
Deferred income	98.0K PEN	138.0K PEN	267.0K PEN
Total current liabilities	1.7B PEN	1.9B PEN	1.7B PEN
Loans and borrowings	3.2B PEN	3.0B PEN	3.4B PEN
Lease liabilities	94.2M PEN	115.4M PEN	126.2M PEN
Trade accounts payable	1.4M PEN	2.7M PEN	3.9M PEN
Other accounts payable	221.9M PEN	73.2M PEN	221.1M PEN
Derivative financial instruments	39.6M PEN	27.1M PEN	0 PEN
Deferred tax liabilities	291.1M PEN	328.4M PEN	495.8M PEN
Deferred income	87.0K PEN	177.0K PEN	352.0K PEN
Total non-current liabilities	3.9B PEN	3.5B PEN	4.2B PEN
Total liabilities	5.5B PEN	5.5B PEN	5.9B PEN
Share capital	17.4M PEN	17.4M PEN	8.8M PEN
Share premium	1.2B PEN	1.2B PEN	0 PEN
Reserves	566.3M PEN	524.8M PEN	1.8B PEN
Retained losses	-192.6M PEN	-273.5M PEN	-366.9M PEN
Equity attributable to the owner of the Company	1.6B PEN	1.5B PEN	1.5B PEN
Non-controlling interest	165.6M PEN	145.7M PEN	311.3M PEN
Total equity	1.8B PEN	1.6B PEN	1.8B PEN
Total liabilities and equity	7.3B PEN	7.1B PEN	7.7B PEN

Cash from operations²668.5M PEN in 2024+311% since 2022

Capital spending²90.9M PEN in 2024−11% since 2022

Free cash flow²577.6M PEN in 2024+860% since 2022

Every line of the cash flow in the latest annual report, as filed.⁴

Period ending	2025-12-31	2024-12-31	2023-12-31
Profit (loss) for the year	110.9M PEN	124.0M PEN	-214.3M PEN
Depreciation	115.4M PEN	115.2M PEN	132.4M PEN
Depreciation of right-of-use assets	28.2M PEN	27.6M PEN	26.6M PEN
Amortization	78.8M PEN	76.3M PEN	76.7M PEN
Change in fair value of investment property	-106.0K PEN	-161.0K PEN	-116.0K PEN
Impairment (reversal) of inventories	668.0K PEN	419.0K PEN	-1.9M PEN
Equity-settled share-based payment transactions	11.2M PEN	9.1M PEN	3.7M PEN
Gain (loss) on disposal of property, furniture, and equipment	-512.0K PEN	4.5M PEN	-696.0K PEN
Gain (loss) on disposal of right-of-use assets net of leases	-20.0K PEN	79.0K PEN	743.0K PEN
Loss on disposal of intangibles	147.0K PEN	1.1M PEN	477.0K PEN
Other expenses for derecognition of other assets		2.1M PEN
Other expenses for changes in contingent consideration			20.9M PEN
Other income for reversal of contingent consideration			-4.1M PEN
Other income for reversal of others accounts payable to former shareholders	0 PEN	-46.6M PEN
Loss for impairment of trade receivables	48.1M PEN	40.9M PEN	5.7M PEN
Share of profit of equity-accounted investees	-10.4M PEN	-8.8M PEN	-6.3M PEN
Provisions	1.3M PEN	1.0M PEN	1.2M PEN
Finance income	-214.8M PEN	-24.8M PEN	-93.0M PEN
Finance costs	651.3M PEN	633.6M PEN	783.8M PEN
Income tax expense	88.4M PEN	59.8M PEN	90.2M PEN
Trade accounts receivable and other assets	-81.6M PEN	-343.2M PEN	-316.0M PEN
Inventories	-17.8M PEN	-25.9M PEN	-30.1M PEN
Trade accounts payable and other accounts payable	64.6M PEN	229.8M PEN	183.7M PEN
Provisions and employee benefits	-3.7M PEN	-5.7M PEN	-4.3M PEN
Insurance contract liabilities	-13.5M PEN	-28.6M PEN	25.1M PEN
Cash generated from operating activities	856.4M PEN	841.8M PEN	680.3M PEN
Income tax paid	-209.0M PEN	-194.3M PEN	-114.7M PEN
Interest received	15.1M PEN	21.0M PEN	16.8M PEN
Net cash from operating activities	662.5M PEN	668.5M PEN	582.4M PEN
Acquisition of subsidiary, net of cash acquired			-60.0M PEN
Payment for accounts payable to former shareholder	-21.1M PEN	-30.0M PEN	-1.4M PEN
Purchase of properties, furniture, and equipment	-86.0M PEN	-90.9M PEN	-116.2M PEN
Purchase of intangibles	-58.7M PEN	-51.0M PEN	-48.9M PEN
Dividends from equity-accounted investees	3.4M PEN	3.3M PEN	1.4M PEN
Other assets (Trust funds)			94.5M PEN
Purchase of other investments, net of sales	75.7M PEN	-21.3M PEN	-22.2M PEN
Proceeds from sale of property, furniture, and equipment	6.5M PEN	213.0K PEN	4.2M PEN
Payment for contingent consideration		-47.2M PEN	-36.1M PEN
Proceeds from (payment in advance for) purchase of shares			11.6M PEN
Net cash used in investing activities	-80.3M PEN	-236.8M PEN	-173.2M PEN
Proceeds from issuance of common stock in initial public offering, net of issuance costs		1.3B PEN
Payments of initial public offering costs		-15.9M PEN
Proceeds from loans and borrowings	4.1B PEN	1.2B PEN	4.9B PEN
Payment for loans and borrowings	-4.0B PEN	-1.1B PEN	-4.5B PEN
Payment for lease liabilities	-43.9M PEN	-45.6M PEN	-42.5M PEN
Penalty paid for debt prepayment	-81.0K PEN		-53.3M PEN
Payment for derivatives premiums	-22.8M PEN	-50.7M PEN	-51.1M PEN
Payment for costs of extinguishment of debt	-64.8M PEN	-16.6M PEN
Interest paid	-408.3M PEN	-451.0M PEN	-566.8M PEN
Proceeds from settlement of derivatives - interest rate swaps	-22.5M PEN	-1.2M PEN
Dividends paid		-1.1M PEN	-6.8M PEN
Contributions from non-controlling shareholders			16.0K PEN
Acquisition of non-controlling interest		-1.2B PEN
Net cash used in financing activities	-487.1M PEN	-418.1M PEN	-370.0M PEN
Net increase in cash and cash equivalents	95.2M PEN	13.6M PEN	39.3M PEN
Effect of movements in exchange rates on cash held	4.5M PEN	-18.9M PEN	-6.8M PEN
Assets acquired through finance lease and other financing	14.7M PEN	26.8M PEN	17.9M PEN
Assets acquired from suppliers in installments	18.4M PEN	10.1M PEN	16.8M PEN

Compare AUNA S.A. with another company

Former names

AUNA S.A.A.Sep 30, 2020 to Mar 14, 2022³

Recent filings

Oct 8, 2026SCHEDULE 13G/A
Aug 18, 20266-K
Aug 12, 2026SCHEDULE 13G/A
Jul 15, 20266-K
Jul 9, 2026SCHEDULE 13G/A
Jul 7, 20266-K
Jun 1, 20263/A
Jun 1, 20264
Jun 1, 20264
May 29, 2026SCHEDULE 13G
May 28, 2026144
May 28, 20264
May 27, 20266-K
May 19, 20266-K
Apr 22, 202620-F

Every filing from the last three years, summarized. The full record is on SEC EDGAR.¹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAUNA S.A. filings on SEC EDGAR
2
SEC EDGARAUNA S.A. 10-K for fiscal 2024
3
SEC EDGARAUNA S.A. filings on SEC EDGAR
4
SEC EDGARAUNA S.A. 20-F for fiscal 2025: revenue by segment